SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001140361-22-025737
Filing Date
2022-07-11
Accepted
2022-07-11 17:12:52
Documents
1

Document Format Files

Seq Description Document Type Size
1 POS AM ny20004305x15_posam.htm POS AM 21901
  Complete submission text file 0001140361-22-025737.txt   22952
Mailing Address 35 GATEHOUSE DRIVE WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE WALTHAM MA 02451 (781) 810-0120
Entasis Therapeutics Holdings Inc. (Filer) CIK: 0001724344 (see all company filings)

IRS No.: 824592913 | State of Incorp.: DE | Fiscal Year End: 1231
Type: POS AM | Act: 33 | File No.: 333-241683 | Film No.: 221077570
SIC: 2834 Pharmaceutical Preparations